世界の血糖モニタリングシステム(CGMS)市場予測2019-2028

◆英語タイトル:GLOBAL GLUCOSE MONITORING SYSTEM MARKET FORECAST 2019-2028
◆商品コード:INK20AG005
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年8月
◆ページ数:210
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥472,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、血糖モニタリングシステム(CGMS)の世界市場について調査を行い、調査手法、エグゼクティブサマリー、市場動向、主要分析、コンポーネント別(センサー、送信機・受信機、一体型インシュリンポンプ)分析、エンドユーザー別分析、年齢別分析、SMBGコンポーネント別分析、SMBGエンドユーザー別分析、SMBG用途別分析、地域別分析、企業情報などをまとめております。
・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・血糖モニタリングシステム(CGMS)の世界市場規模:コンポーネント別(センサー、送信機・受信機、一体型インシュリンポンプ)
・血糖モニタリングシステム(CGMS)の世界市場規模:エンドユーザー別
・血糖モニタリングシステム(CGMS)の世界市場規模:年齢別
・自己血糖測定(SMBG)市場概要
・自己血糖測定(SMBG)の世界市場規模:コンポーネント別
・自己血糖測定(SMBG)の世界市場規模:エンドユーザー別
・自己血糖測定(SMBG)の世界市場規模:用途別
・地域別分析
・企業情報






【レポートの概要】

KEY FINDINGS
The global glucose monitoring system CGMS market is anticipated to grow at a CAGR of 22.31%, and the SMBG market is estimated to grow at 5.22% over the forecast period of 2019-2028. The various factors stimulating global market growth are surge in diabetes incidences, rise in healthcare expenditure, growing emphasis on R&D, technology amalgamation, economical CGMS AND SMBG, technological development in GMS devices, and growing awareness among people.

MARKET INSIGHTS
The advent of continuous glucose monitoring systems (CGMS) is a major achievement in glucose monitoring for diabetic patients. Conventionally, CGMS faced competition from finger-based self-monitoring blood glucose (SMBG) devices, as they are affordable, easy-to-use, and easily approved by the authorities. However, CGMS has been well accepted in the US, and increasing its presence in other countries as well. There is an exceptional rise in the diabetic population all over the world, which is driving the market. Eating habits, changing lifestyles, and less physical activities are the major causes of type 2 diabetes in adults. However, type 1 diabetes has also increased.
Government regulations are hindering the growth of the market. The glucose monitoring market is highly regulated by strict rules and approval issues from government authorities, especially the US FDA, which has very stringent regulations. All the companies are focusing on developing innovative and technologically advanced products to stay competitive in the market. The sensors category in the CGMS market by component type segment captured the largest market share in 2019. The sensors dispense signals to show the real-time glucose level of the patients. Lancets are the fastest-growing component type in the SMBG market.

REGIONAL INSIGHTS
The geographical analysis of the global glucose monitoring system market includes market evaluation of North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific is the fastest-growing region for both, SMBG and CGMS market. This is mainly due to the growing prevalence of diabetes in the region.

COMPETITIVE INSIGHTS
The introduction of new technologies, coupled with mergers and acquisitions, is resulting in a high competitive rivalry in the market. Some of the eminent players operating in the market are Ypsomed, Abbott Diagnostic, Medtronic, Inc, Terumo, Wockhardt, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARIES
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. RISE IN THE INCIDENCE OF DIABETES
3.2.2. INCREASE IN HEALTHCARE EXPENDITURE
3.2.3. INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
3.2.4. TECHNOLOGY INTEGRATION
3.2.5. INCREASING CGMS AND SMBG AFFORDABILITY
3.2.6. TECHNOLOGICAL ADVANCES IN GMS DEVICES
3.2.7. AWARENESS AMONG THE GENERAL POPULATION
3.3. KEY RESTRAINTS
3.3.1. HINDRANCE FROM GOVERNMENT REGULATIONS
3.3.2. INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
3.3.3. LACK OF AWARENESS OF THE DIAGNOSTIC OPPORTUNITIES
3.3.4. INTENSE COMPETITION AMONG VENDORS
3.3.5. INACCURACY IN READING OF GMS DEVICES
4. KEY ANALYTICS
4.1. PORTER’S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER’S POWER
4.1.4. SUPPLIER’S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. KEY BUYING CRITERIA
4.3. REGULATION OF BLOOD SUGAR
4.4. VALUE CHAIN ANALYSIS
4.5. OPPORTUNITY MATRIX
4.6. VENDOR LANDSCAPE
4.7. KEY INVESTMENT INSIGHTS
5. CGMS MARKET BY COMPONENT TYPE
5.1. SENSORS
5.2. TRANSMITTER AND RECEIVERS
5.3. INTEGRATED INSULIN PUMPS
6. CGMS MARKET BY END-USER
6.1. HOME SETTINGS
6.2. DIAGNOSTICS AND CLINICAL
6.3. HOSPITAL
7. CGMS MARKET BY DEMOGRAPHICS
7.1. ADULT POPULATION (>14YEARS)
7.2. CHILD POPULATION (≤14YEARS)
8. SMBG MARKET OVERVIEW
9. SMBG MARKET BY COMPONENT TYPE
9.1. TEST STRIPS
9.2. GLUCOSE METER
9.3. LANCETS
10. SMBG MARKET BY END USER
10.1. HOME SETTINGS
10.2. CLINICAL
10.3. HOSPITAL
11. SMBG MARKET BY APPLICATION
11.1. TYPE 1 DIABETES
11.2. TYPE 2 DIABETES
11.3. GESTATIONAL DIABETES
12. GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1. THE UNITED STATES
12.1.1.1. THE UNITED STATES HEALTH AND HEALTHCARE
12.1.1.2. THE UNITED STATES PHARMACEUTICAL MARKET
12.1.2. CANADA
12.1.2.1. CANADA HEALTH AND HEALTHCARE
12.1.2.2. CANADA PHARMACEUTICAL MARKET
12.1.2.3. CANADA DIABETES MARKET
12.2. EUROPE
12.2.1. GERMANY
12.2.1.1. GERMANY HEALTH AND HEALTHCARE
12.2.1.2. GERMANY PHARMACEUTICAL MARKET
12.2.2. THE UNITED KINGDOM
12.2.2.1. THE UNITED KINGDOM HEALTH AND HEALTHCARE
12.2.2.2. THE UNITED KINGDOM HEALTHCARE PROVISION
12.2.2.3. THE UNITED KINGDOM PRIVATE SECTOR INVOLVEMENT
12.2.2.4. THE UNITED KINGDOM PHARMACEUTICALS
12.2.3. FRANCE
12.2.3.1. FRANCE HEALTH AND HEALTHCARE
12.2.3.2. FRANCE HEALTHCARE PROVISION
12.2.4. RUSSIA
12.2.4.1. RUSSIA HEALTH AND HEALTHCARE
12.2.4.2. RUSSIA PHARMACEUTICAL SERVICES
12.2.5. ITALY
12.2.5.1. ITALY HEALTH AND HEALTHCARE
12.2.5.2. ITALY HEALTHCARE PROVISION
12.2.5.3. ITALY PHARMACEUTICAL MARKET
12.2.6. BELGIUM
12.2.7. POLAND
12.2.8. REST OF EUROPE (ROE)
12.3. ASIA PACIFIC
12.3.1. CHINA
12.3.1.1. CHINA HEALTH AND HEALTHCARE
12.3.1.2. CHINA PHARMACEUTICAL MARKET
12.3.1.3. CHINA DIABETES MARKET
12.3.1.4. MARKET TRENDS
12.3.2. INDIA
12.3.2.1. INDIA HEALTH AND HEALTHCARE
12.3.2.2. INDIA REGULATORY CHANGES
12.3.2.3. INDIA PHARMACEUTICAL MARKET
12.3.2.4. INDIA DIABETES MARKET
12.3.3. AUSTRALIA
12.3.3.1. MARKET TRENDS
12.3.4. JAPAN
12.3.4.1. JAPAN HEALTH AND HEALTHCARE
12.3.4.2. JAPAN PHARMACEUTICAL MARKET
12.3.4.3. JAPAN DIABETES MARKET
12.3.4.4. MARKET TRENDS
12.3.5. SOUTH KOREA
12.3.5.1. MARKET TRENDS
12.3.6. INDONESIA
12.3.6.1. MARKET TRENDS
12.3.7. MALAYSIA
12.3.7.1. MARKET TRENDS
12.3.8. PHILIPPINES
12.3.8.1. MARKET TRENDS
12.3.9. THAILAND
12.3.9.1. MARKET TRENDS
12.3.10. VIETNAM
12.3.10.1. MARKET TRENDS
12.3.11. REST OF APAC
12.4. REST OF WORLD
12.4.1. LATIN AMERICA
12.4.1.1. BRAZIL HEALTH AND HEALTHCARE
12.4.1.2. BRAZIL PHARMACEUTICAL MARKET
12.4.1.3. MEXICO HEALTH AND HEALTHCARE
12.4.1.4. MEXICO PHARMACEUTICAL MARKET
12.4.2. MIDDLE EAST AND AFRICA
13. COMPANY PROFILES
13.1. ABBOTT
13.2. APEX BIOTECHNOLOGY CORPORATION
13.3. ARKRAY INC
13.4. ASCENSIA
13.5. B BRAUN MELSUNGEN AG
13.6. BECTON DICKINSON AND COMPANY
13.7. DEXCOM
13.8. GLYSENS INC
13.9. INSULET CORP
13.10. I-SENS INC
13.11. JOHNSON AND JOHNSON
13.12. MEDTRONIC
13.13. MOREPEN LABORATORIES LTD
13.14. NEMAURA MEDICAL INC
13.15. ROCHE DIAGNOSTICS
13.16. SENSEONICS INC
13.17. TANDEM DIABETES CARE
13.18. TERUMO
13.19. WOCKHARDT
13.20. YPSOMED

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - GLUCOSE MONITORING SYSTEM
TABLE 2: DIABETES PREVALENCE IN VARIOUS REGION 2015-2040 (MILLIONS)
TABLE 3: GLOBAL CGMS MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 4: GLOBAL CGMS MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 5: GLOBAL SENSORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 6: GLOBAL SENSORS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 7: GLOBAL TRANSMITTER AND RECEIVERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 8: GLOBAL TRANSMITTER AND RECEIVERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 9: GLOBAL INTEGRATED INSULIN PUMPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 10: GLOBAL INTEGRATED INSULIN PUMPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 11: GLOBAL CGMS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 12: GLOBAL CGMS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 13: GLOBAL HOME SETTINGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 14: GLOBAL HOME SETTINGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 15: GLOBAL DIAGNOSTICS AND CLINICAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 16: GLOBAL DIAGNOSTICS AND CLINICAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 17: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 18: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 19: GLOBAL CGMS MARKET, BY DEMOGRAPHICS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 20: GLOBAL CGMS MARKET, BY DEMOGRAPHICS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 21: GLOBAL ADULT POPULATION (>14YEARS) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 22: GLOBAL ADULT POPULATION (>14YEARS) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 23: GLOBAL CHILD POPULATION (≤14YEARS) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 24: GLOBAL CHILD POPULATION (≤14YEARS) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 25: IMPORTANT ASPECTS FOR THE USE OF SMBG DEVICES IN HOME-CARE SETTINGS
TABLE 26: SMBG STRIPS USAGE SCENARIO IN SELECTED COUNTRIES IN AMERICAS
TABLE 27: PRODUCT MATRIX FOR LANCETS
TABLE 28: GLOBAL SMBG MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 29: GLOBAL SMBG MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 30: GLOBAL TEST STRIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 31: GLOBAL TEST STRIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 32: GLOBAL GLUCOSE METER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: GLOBAL GLUCOSE METER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 34: GLOBAL LANCETS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 35: GLOBAL LANCETS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 36: GLOBAL SMBG MARKET, BY END USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 37: GLOBAL SMBG MARKET, BY END USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 38: GLOBAL HOME SETTINGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 39: GLOBAL HOME SETTINGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 40: GLOBAL CLINICAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 41: GLOBAL CLINICAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 42: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 43: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 44: GLOBAL SMBG MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 45: GLOBAL SMBG MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 46: GLOBAL TYPE 1 DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 47: GLOBAL TYPE 1 DIABETES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 48: GLOBAL TYPE 2 DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 49: GLOBAL TYPE 2 DIABETES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 50: GLOBAL GESTATIONAL DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 51: GLOBAL GESTATIONAL DIABETES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 52: GLOBAL CGMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 53: GLOBAL CGMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 54: GLOBAL SMBG MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 55: GLOBAL SMBG MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 56: NORTH AMERICA CGMS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 57: NORTH AMERICA CGMS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 58: NORTH AMERICA SMBG MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 59: NORTH AMERICA SMBG MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 60: EUROPE CGMS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 61: EUROPE CGMS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 62: EUROPE SMBG MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 63: EUROPE SMBG MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 64: AVERAGE PRICES IN GERMANY FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER
TABLE 65: GERMANY SMBG SALES CHANNEL 2019-2028 ($ MILLION)
TABLE 66: AVERAGE PRICES IN UK FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER
TABLE 67: THE UNITED KINGDOM SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
TABLE 68: ASIA PACIFIC CGMS, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 69: ASIA PACIFIC CGMS, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 70: ASIA PACIFIC SMBG, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 71: ASIA PACIFIC SMBG, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 72: AVERAGE PRICES IN CHINA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER
TABLE 73: CHINA SMBG SALES CHANNEL 2019-2028 ($ MILLION)
TABLE 74: AVERAGE PRICES IN INDIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 75: INDIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
TABLE 76: AVERAGE PRICES IN AUSTRALIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 77: AUSTRALIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
TABLE 78: AVERAGE PRICES IN JAPAN FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 79: JAPAN SALES CHANNEL, 2019-2028 ($ MILLION)
TABLE 80: AVERAGE PRICES IN SOUTH KOREA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 81: SOUTH KOREA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
TABLE 82: AVERAGE PRICES IN INDONESIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 83: INDONESIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
TABLE 84: AVERAGE PRICES IN MALAYSIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 85: MALAYSIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
TABLE 86: AVERAGE PRICES IN PHILIPPINES FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 87: PHILIPPINES SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
TABLE 88: AVERAGE PRICES IN THAILAND FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 89: THAILAND SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
TABLE 90: AVERAGE PRICES IN VIETNAM FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)
TABLE 91: VIETNAM SMBG SALES CHANNEL, 2019-2028 ($ MILLION)
TABLE 92: REST OF WORLD CGMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 93: REST OF WORLD CGMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 94: REST OF WORLD SMBG MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 95: REST OF WORLD SMBG MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の血糖モニタリングシステム(CGMS)市場予測2019-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆